Artificial Intelligence and its growing role in dermatology
DOI:
https://doi.org/10.66344/jpad.v30i4.1633Keywords:
Artificial Intelligence, dermatologyReferences
Li Cheng-Xu1, Shen Chang-Bing, Xue Ke1, Shen Xue, Jing Yan, Wang Zi-Yi, Xu Feng, Meng Ru-Song, Yu Jian-Bin, Cui Yong. Artificial intelligence in dermatology, Chinese Med J. 2019; 132(17):2017-20. doi:10.1097/CM9.0000000000000372
Alabulkareem A. Artificial intelligence and dermatologists: Friends or foes? J Dermatol Dermatol Surg 2019;23:57-60.
Gomolin A, Netchiporouk E, Gniadecki R and Litvinov IV. Artificial Intelligence Applications in Dermatology: Where Do We Stand? Front. Med 2020; 7:100. doi: 10.3389/fmed.2020.00100
de Carvalho TM, Noels E, Wakkee M, Udrea A, Nijsten T. Development of smartphone apps for skin cancer risk assessment: progress and promise. JMIR Dermatol 2019; 2(1):e13376. DOI: 10.2196/13376
Artificial intelligence in dermatology-codes and concepts. Available at: https://dermnetnz.org/topics/artificial-intelligence/
AI could revolutionise dermatology, but key hurdles remain. Available at: https://www.medicaldevice-network.com/comment/ai-in-dermatology/
Du‐Harpur X, Watt F, Luscombe N, Lynch M. What is AI? Applications of artificial intelligence to dermatology. Br J Dermatol 2020; 183: 423-30. doi:10.1111/bjd.18880.
Downloads
Published
Issue
Section
License
Copyright (c) 2021 Amina Afzal, Shehla Shaukat, Mahwish Zahoor, Ijaz Hussain

This work is licensed under a Creative Commons Attribution 4.0 International License.
Submission declaration
Authors retain the copyright to their work and grant the 'Journal of Pakistan Association of Dermatologists (JPAD)' the right of first publication under a Creative Commons Attribution 4.0 International (CC BY 4.0) license. This license allows others to share, adapt, and reuse the work for any purpose, including commercial use, as long as appropriate credit is given to the original authors and the journal.
By submitting a manuscript, authors confirm that the work has not been published previously (except as an abstract, lecture, or academic thesis), is not under review elsewhere, and has been approved by all authors and relevant authorities. Once accepted, the article will be openly accessible under the CC BY 4.0 license, ensuring wide dissemination and reuse with proper attribution.






